Event
Date: October 30, 2019
Location: Regenstrief Institute, 1101 W. 10th St., Indianapolis, IN 46202

SAM Talk: Featuring Dr. Claire Snyder, MHS, PhD

“Personalizing Care Using Patient-Reported Outcomes”

The 2019-2020 Sam Regenstrief Lecture Series

October 30, 2019  11:30AM-12:30PM

Regenstrief Institute, 1101 W. 10th St., Indiananpolis, IN 46202

Claire Snyder, MHS, PhDDr. Claire Snyder researches the quality of cancer care, with a particular focus in quality of life for cancer patients and coordination of care between cancer specialists and primary care providers.

She is investigating the use of patient-reported outcome questionnaires in routine oncology practice. This intervention involves having patients complete questionnaires regarding their functioning and well-being, providing the responses to their clinicians, and evaluating whether the questionnaires help their clinicians identify and address these quality-of-life issues.

In related research, she has developed the PatientViewpoint web tool for collecting these questionnaires and linking the results with the electronic medical record.

Dr. Snyder has also conducted multiple studies using large databases to examine the quality of care for cancer survivors — including preventive and primary care services, comorbid condition care, and cancer follow-up. A particular focus is how involvement of different physician specialties relates to whether survivors receive recommended follow-up. She is also working with a multidisciplinary team to develop survivorship care strategies at Johns Hopkins. Dr. Snyder holds a joint appointment in Health Policy and Management with the Bloomberg School of Public Health.

Related News

Regenstrief experts advance global dialogue on digital health and interoperability at forum in Dubai

Regenstrief informaticians joined global leaders who shared their expertise at the 8th ZIMAM Digital Health Forum November 5-6, in

Regenstrief researchers join national stage to advance aging and gerontology research

Regenstrief Institute research scientists joined leading experts from across the nation at the Gerontological Society of America (GSA) 2025

illustration of the combination of interventions used in the D3 pragmatic clinical trial

Zero-cost, AI-driven digital detection identifies Alzheimer’s and related dementias without additional clinician time

Few primary care practices are designed for the timely detection of Alzheimer’s disease and related dementias. The limited time